EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieVergleichsstudie

Immediate discontinuation versus gradual tapering of proton pump inhibitors in long-term users: a randomized controlled trial

Mariko Hojo iD, Kumiko Ueda, Hiroya Ueyama, Tsutomu Takeda, Shotaro Oki, Daiki Abe, Kei Nomura, Takashi Murakami, Dai Ishikawa, Yuji Shimada, Daisuke Asaoka, Ryunosuke Okahara und 3 weitere

Journal of Gastroenterology · 2026-08 · 61 (8) · 1083-1092

DOI: 10.1007/s00535-026-02419-z ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Gastroenterology, online erschienen am 27.04.2026. Verfasst von Mariko Hojo und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Faculty of Medicine, Juntendo University, Bunkyo-ku, Tokyo, Japan. mhojo@juntendo.ac.jp. Hauptthemen laut MEDLINE: Proton Pump Inhibitors, Gastroesophageal Reflux, Drug Tapering. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: CORE project funded by Juntendo University Medical Technology Innovation Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Proton pump inhibitors (PPIs) are often continued after symptoms have improved, despite no clear indications for maintenance therapy. Although unnecessary long-term PPI use should be avoided, concerns about symptom rebound after discontinuation frequently discourage withdrawal; evidence comparing discontinuation strategies remains insufficient. METHODS: We conducted a multicenter, randomized, parallel-group trial comparing immediate discontinuation and gradual tapering of PPIs, including PCABs, in clinically stable outpatients with gastroesophageal reflux disease receiving long-term PPI therapy. Participants were randomized 1:1 to abrupt discontinuation or dose reduction to half for 2 weeks followed by discontinuation. Rescue PPI use was permitted as needed. Successful discontinuation was defined as ≤ 8 days of rescue PPI use during each 28-day assessment window. The primary outcome was successful discontinuation at 24 weeks, and the secondary outcome was successful discontinuation at 48 weeks. Analyses were performed primarily in the intention-to-treat population. RESULTS: Sixty-three participants were randomized. At 24 weeks, successful discontinuation was achieved in 74.2% of the immediate discontinuation group and 75.0% of the gradual taper group (risk difference: - 0.008, 95% CI: - 0.231 to 0.215). Results were similar at 48 weeks and in per-protocol analyses. No protocol-specified adverse events were observed. On exploratory analyses, older age and lower baseline regurgitation score were associated with successful discontinuation. Rescue medication use occurred early after discontinuation but did not preclude long-term success. CONCLUSIONS: Immediate discontinuation and gradual tapering resulted in comparable rates of successful PPI withdrawal in clinically stable patients. Counseling regarding transient symptoms and on-demand rescue therapy may facilitate successful discontinuation regardless of strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proton Pump InhibitorsGastroesophageal RefluxDrug TaperingHumansFemaleMaleTime FactorsMiddle AgedAgedTreatment InterruptionDrug Administration ScheduleTreatment Outcome

Stichwörter der Autor:innen

DiscontinuationProton pump inhibitorsRescue medicationTapering

Substanzen

Proton Pump Inhibitors

Autor:innen und Institutionen

  • Department of Gastroenterology, Faculty of Medicine, Juntendo University, Bunkyo-ku, Tokyo, Japan. mhojo@juntendo.ac.jp.
  • Department of Pathophysiological Research and Therapeutics for Gastrointestinal Disease, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan. mhojo@juntendo.ac.jp.
  • Department of Gastroenterology, Faculty of Medicine, Juntendo University, Bunkyo-ku, Tokyo, Japan.
  • Department of Pathophysiological Research and Therapeutics for Gastrointestinal Disease, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan.
  • Department of Gastroenterology, Juntendo University Shizuoka Hospital, Izunokuni-Shi, Shizuoka, Japan.
  • Department of Gastroenterology, Juntendo Tokyo Koto Geriatric Medical Center, Koto-ku, Tokyo, Japan.

ORCID-Profile: Mariko Hojo

Förderung

  • CORE project funded by Juntendo University Medical Technology Innovation Center

Zitieren

APA

Hojo, M., Ueda, K., Ueyama, H., Takeda, T., Oki, S., Abe, D., Nomura, K., Murakami, T., Ishikawa, D., Shimada, Y., Asaoka, D., Okahara, R., Nojiri, S., Shibuya, T., & Nagahara, A. (2026). Immediate discontinuation versus gradual tapering of proton pump inhibitors in long-term users: a randomized controlled trial. Journal of Gastroenterology, 61(8), 1083-1092. https://doi.org/10.1007/s00535-026-02419-z

Vancouver

Hojo M, Ueda K, Ueyama H, Takeda T, Oki S, Abe D, et al. Immediate discontinuation versus gradual tapering of proton pump inhibitors in long-term users: a randomized controlled trial. Journal of Gastroenterology. 2026;61(8):1083-1092. doi:10.1007/s00535-026-02419-z

BibTeX
@article{Hojo2026,
  author = {Hojo, Mariko and Ueda, Kumiko and Ueyama, Hiroya and Takeda, Tsutomu and Oki, Shotaro and Abe, Daiki and Nomura, Kei and Murakami, Takashi and Ishikawa, Dai and Shimada, Yuji and Asaoka, Daisuke and Okahara, Ryunosuke and Nojiri, Shuko and Shibuya, Tomoyoshi and Nagahara, Akihito},
  title = {Immediate discontinuation versus gradual tapering of proton pump inhibitors in long-term users: a randomized controlled trial},
  journal = {Journal of Gastroenterology},
  year = {2026},
  volume = {61},
  number = {8},
  pages = {1083--1092},
  doi = {10.1007/s00535-026-02419-z}
}
Kostenlos starten →